Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus.
about
Glia in the cytokine-mediated onset of depression: fine tuning the immune responseUnmet medical needs in systemic lupus erythematosusNeuropsychiatric lupus: a mosaic of clinical presentationsBipolar I and II Disorders; A Systematic Review and Meta-Analysis on Differences in Comorbid Obsessive-Compulsive DisorderLupus brain fog: a biologic perspective on cognitive impairment, depression, and fatigue in systemic lupus erythematosusThe MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus.Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus.An evolutionary hypothesis of suicide: why it could be biologically adaptive and is so prevalent in certain occupations.Monocyte and lymphocyte activation in bipolar disorder: a new piece in the puzzle of immune dysfunction in mood disorders.The immunology of bipolar disorderStress Intervention and Disease in African American Lupus Patients: The Balancing Lupus Experiences with Stress Strategies (BLESS) Study.A Case of Mania in a Patient with Systemic Lupus Erythematosus: Can Its Inflammatory Pathogenesis be Applied to Primary Mood Disorders?Prevalence of depression and depressive symptoms in patients with systemic lupus erythematosus: Iranian experience.Depression and anxiety and their association with healthcare utilization in pediatric lupus and mixed connective tissue disease patients: a cross-sectional study.Cytokines in bipolar disorder: paving the way for neuroprogression.Maternal history of autoimmune disease in children presenting with tics and/or obsessive-compulsive disorder.Psychosocial dimensions of SLE: implications for the health care teamDiagnostic validity of comorbid bipolar disorder and obsessive-compulsive disorder: a systematic review.The inflammasome: pathways linking psychological stress, depression, and systemic illnessesIntervention to Improve Quality of life for African-AmericaN lupus patients (IQAN): study protocol for a randomized controlled trial of a unique a la carte intervention approach to self-management of lupus in African Americans.Prevalence of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysisFactors associated with pain coping and catastrophising in patients with systemic lupus erythematosus: a cross-sectional study of the LuLa-cohortStress and Depression in Relation to Functional Health Behaviors in African American Patients with Systemic Lupus Erythematosus.Decreased serum level of soluble-leptin-receptor in patients with systemic lupus erythematosus.Depressive symptoms are associated with tumor necrosis factor alpha in systemic lupus erythematosus.Association between depression and vascular disease in systemic lupus erythematosusPrevalence and predictors of depression in patients with systemic lupus erythematosus: a cross-sectional study.The correlations of disease activity, socioeconomic status, quality of life, and depression/anxiety in Chinese patients with systemic lupus erythematosus.Cardiovascular and disease-related predictors of depression in systemic lupus erythematosus.Ovarian Damage During chemotherapy in Autoimmune Diseases: Broad Health Implications beyond Fertility.Depressive and Anxiety Disorders in Systemic Lupus Erythematosus Patients without Major Neuropsychiatric ManifestationsAnti-ribosomal P antibodies related to depression in early clinical course of systemic lupus erythematosus.Updated review of complementary and alternative medicine treatments for systemic lupus erythematosus.Silent Burdens in Disease: Fatigue and Depression in SLEIdentifying Differences in Risk Factors for Depression and Anxiety in Pediatric Chronic Disease: A Matched Cross-Sectional Study of Youth with Lupus/Mixed Connective Tissue Disease and Their Peers with Diabetes.Resilience and treatment adhesion in patients with systemic lupus erythematosus.Increased expression of human T-cell immunoglobulin- and mucin-domain-containing molecule-4 in peripheral blood mononuclear cells from patients with system lupus erythematosusNeuropsychiatric lupus: clinical challenges, brain-reactive autoantibodies and treatment strategies.The economic burden of systemic lupus erythematosus in Asia: the current state.Neuropsychiatric manifestations in systemic lupus erythematosus: epidemiology, pathophysiology and management.
P2860
Q26798929-894C7436-5FE2-491E-94B0-55D7B1D57FC4Q27005906-C51AF4B4-2E87-47F7-8C0E-BE0F594EE1CCQ27027588-1AB2B8D8-DA45-4E36-B7C0-A5EAF73EF9E5Q28079120-D64A7198-2DDF-4107-BD67-0253029FFCCDQ28268802-6F411370-6E16-4A40-8576-89051DBDFE31Q30476952-7D3380D6-28F6-4D47-BBB5-CEDC074DD671Q30580226-E9C6891A-5F04-43AA-BF3B-6DDFD60A9E4FQ33352057-E98862C4-D95B-4FA8-9390-7B4B293CC35EQ33359759-899D8C77-51CA-4735-8695-1296B0D81260Q33698965-6B6C5F82-B823-4DAD-B6D9-C0FB2ABED556Q33738700-B5C35C95-E4B3-4D21-B0C0-2019888B4782Q33881567-3EF7DAB4-E702-4E4C-88F8-42EBED781001Q34160129-6706B646-AD66-48D3-9AA9-57FAA8C16D16Q34217233-A6368ABF-2E2E-4032-B4FA-BF8FAE029872Q34233926-E3D04F67-21EC-4043-B27A-667F9A3C35E5Q34348432-84C28DB9-4C90-43F1-8742-9B2A3074D0D0Q34979305-05D5D2D4-124F-4A75-B64C-7441AE12AB16Q35088827-5C482DDB-706F-4F8F-A099-6C7BA4B07305Q35592049-272BD07A-B05B-4385-9091-93D259CC3CD3Q36093309-2BAEBBD7-21A8-4528-A20C-244206EE71C3Q36280424-D5087335-CDF6-4364-AE84-79BDAC5D83B8Q36302250-E75EDD74-301F-46F9-9EDE-AE7EEE8B2A88Q36326662-AA033B84-B53E-4C99-B34A-8AE748877DBDQ36350897-D9AB8DC4-9441-432F-B63C-C79BB825A04DQ36433143-0DC3C667-994E-45B3-894E-80643C697B88Q36784328-E943E8B4-EA81-4962-8D91-EBFB65936990Q36919545-B27440D0-6062-4820-9579-965A0FAA61C6Q36995399-F1867EB9-7AE2-4055-807C-93828AD2870DQ37019825-507F0D6F-C0D5-4ADD-BEF5-8D690DF88AE3Q37105605-97DCECB0-B5FF-4E7C-AEE2-0AD0C397914EQ37323676-4D43B441-20C5-493D-907A-7F0B7DCD8433Q37498220-C778E3C6-4EAB-47E2-91F3-B15FA4CA7408Q37504605-02E3F332-837F-476F-B6A3-38BAB81DDD21Q37588327-C99CB48E-2F57-4748-9907-1C2D27A1DD24Q37621292-E00825B7-182F-4E78-AF48-FC81916B40F8Q37657485-AC5FBDCD-5F8F-4999-829A-D429B0E30ECFQ37727271-F36243C2-52B0-4C73-834E-313F3ADA43A5Q37800296-517AC81A-36AD-4A77-8E9B-5B48C9214601Q37800303-214CF61D-E0C1-4634-A8A4-4AEE0863A80EQ37922765-697FE464-D66F-4923-BCD0-C83F06B19401
P2860
Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus.
@en
Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus.
@nl
type
label
Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus.
@en
Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus.
@nl
prefLabel
Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus.
@en
Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus.
@nl
P2093
P2860
P356
P1476
Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus.
@en
P2093
Elizabeth A Bachen
Lindsey A Criswell
Margaret A Chesney
P2860
P304
P356
10.1002/ART.24519
P577
2009-06-01T00:00:00Z